ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 699671 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 699671; 2) Community: the network communities that were significantly associated with the response to NSC 699671; 3) Molecule: the relationships between components within communities and NSC 699671; 4) MDR: the compounds that were significantly associated with the NSC 699671.

NSC Compound Enrichment Correlation
NSC 87500 Solacongestidine 0.0187770954927753 0.36716268
NSC 621888 Cyclopentanone, 2-[(dimethylamino)methyl]-, hydrochloride (9CI) 0.0242256744004388 0.78054362
NSC 668261 Null 0.0242256744004388 0.7057697
NSC 131233 Cyclopentanone, 2,5-bis[(dimethylamino)methyl]-, dihydrochloride 0.024789837445214 0.7294563
NSC 251668 OVATIFOLIN ACETATE 0.024789837445214 0.81476602
NSC 26040 1-Piperidineethanol, .alpha.-[p-(p-chlorostyryl)phenyl]- 0.024789837445214 0.30833488
NSC 267461 Nanaomycin 0.024789837445214 0.7693238
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.024789837445214 0.69550357
NSC 628917 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide 0.024789837445214 0.54885351
NSC 638302 Null 0.024789837445214 0.56667444
Total:119  Current:64    [First] [Prev] [Next] [Last]